Not logged in, please login to view portfolio!

Registration Open


HINOON Share Price | Highnoon Laboratories Limited

HINOON Share Price History

HINOON (Highnoon Laboratories Limited) listed in PSX,ALLSHR,KMIALLSHR,KSE100,MII30. HINOON share price / stock price today is 725.00 PKR. Today volume traded in HINOON is 924, price change is -0.01%, high price is 739.00 PKR, and low price is 702.20 PKR.

HINOON Performance
Return (%) Absolute Return
1 Week 1 Month 3 Month 6 Month 1 Year
Return -0.82% 8.01% 42.85% 54.12% 119.05%

Company Snapshot

loading
HINOON
2024-06-20 10:33:40
Current
725.00
Change
-0.04
Change %
-0.01%
Volume
924.00
Price to Earnings Ratio
15.23
Earning per Share
47.94
Book Value
195.48
Price to Book
2.61
Market Cap
38.41 B
Dividend
30.00
Dividend Yield (%)
5.89 %
Debt to Equity
5.83
Net Profit Margin
12.60 %
Gross Profit Margin
48.45 %
Current Ratio
4.65
Face Value
10.00
Shares
52.98 M
FreeFloat
23.84 M
Free Float %
45.00
Equity to Asset(%)
72.67
Interest
26.70
Beta
0.837
Upper/Lower Cap
786.67 / 663.41
Times-Revenue Method New
52 Week High
745.00
52 Week Low
322.10
High
739.00
Low
702.20
Previous
725.04
loading

Company Brands

image
image
image
image
image
Company Financials
Company Announcements
Date Announce Title Attachments
2024-05-16 Material Information View PDF
2024-05-14 Dispatch of Final Divident Warrants View
2024-05-08 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2024-05-06 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2024-05-03 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2024-05-02 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2024-05-02 Extract of Resolutions Passed at the 41st Annual General Meeting View PDF
2024-04-29 Transmission of Quarterly Report for the period ended 31 March 2024 View PDF
2024-04-29 Financial Results for the 1st Quarter ended 31 March 2024 View PDF
2024-04-26 Corporate Briefing Session Presentation View PDF
2024-04-23 Corporate Briefing Session View PDF
2024-04-23 Board Meeting View
2024-04-09 Transmission of Annual Report for the year ended 31 December 2023 View PDF
2024-04-08 Notice of Annual General Meeting View PDF
2024-03-29 Financial Results for the year ended 31 December 2023 View PDF
2024-03-28 Board Meeting in Progress View
2024-03-21 Board Meeting View
2024-02-23 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2024-02-21 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2024-02-20 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2024-02-14 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2024-01-17 Approval of Budget and Annual Capital for the Financial Year 2024 View
2024-01-09 Board Meeting other than Financial Results View
2023-10-30 Transmission of Quarterly Report for the period ended 30 September 2023 View PDF
2023-10-30 Financial Results for the Quarter ended 30 September 2023 View PDF
2023-10-23 Board Meeting View
2023-09-04 Tranmission of Quarterly Report for the period ended 30 June 2023 View PDF
2023-08-31 Half Year Report 2023 View
2023-08-17 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2023-08-17 Financial Results for the Quarter ended 30 June 2023 View PDF
2023-08-15 Financial Results for the Half Year ended on 30 June 2023 View PDF
2023-08-15 Material Information View PDF
2023-08-07 Board Meeting View
2023-06-27 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2023-06-26 Credit of Bonus Share Certificates View
2023-06-23 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2023-06-12 Extract of Resolution passed at the Board of Directors Meeting View PDF
2023-06-12 Declaration of Interim Bonus Shares Issue View PDF
2023-06-09 Board Meeting in Progress View
2023-06-07 Emergent Board Meeting View PDF
2023-05-29 Credit of Bonus Share Certificates View
2023-05-15 Dispatch of Final Dividend Warrants View
2023-05-02 Transmission of Quarterly Report for the period ended 31 March 2023 View PDF
2023-05-02 Financial Results for the Quarter ended 31 March 2023 View PDF
2023-04-20 Corporate Briefing Session View PDF
2023-04-19 Board Meeting View
2023-04-07 Book Closure Dates View PDF
2023-04-07 Publication of Notice of Annual General Meeting in Newspapers View PDF
2023-04-07 Notice of Annual General Meeting View PDF
2023-04-07 Transmission of Annual Report for the year ended 31 December 2022 View PDF
2023-03-27 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2023-02-23 Appointment of Director View
2023-02-23 Financial Results for the Year ended 31 December 2022 View PDF
2023-02-16 Board Meeting View
2023-01-20 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2023-01-17 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2022-12-19 Resignation of Director View
2022-12-12 Board Meeting Other Than Financial Results View
2022-12-12 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2022-12-02 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2022-11-23 Change of Company Secretary View
2022-10-31 Transmission of Quarterly Report View PDF
2022-10-27 Financial Results for the Quarter Ended September 30,2022 View PDF
2022-10-20 Board Meeting View PDF
2022-09-01 Material Information View PDF
2022-08-31 Transmission of Quarterly Report for the period ended June 30,2022 View PDF
2022-08-15 Financial Results for the half year ended June 30,2022 View PDF
2022-08-05 Board Meeting View PDF
2022-06-16 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2022-06-15 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations REVOKED View
2022-06-15 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2022-05-20 Credit of Bonus Share Certifcates View
2022-05-09 Transmission of Quarterly Report View PDF
2022-05-09 Credit of Final Cash Dividend View
2022-04-11 Board Meeting View PDF
2022-04-11 Material Information View PDF
2022-03-31 Disclosure of Material Information View PDF
2022-03-29 Transmission of Annual Report for the year ended December 31,2021 View PDF
2022-03-28 Notice of Annual General Meeting PDF
2022-03-28 Notice of Annual General Meeting PDF
2022-03-17 Issue Of Bonus Shares View PDF
2022-03-16 Financial Results for the year ended December 31,2021 View PDF
2022-03-09 Board Meeting for Approval of Annual Accounts View PDF
2021-12-27 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2021-10-29 Transmission of Quarterly Report for the period ended September 30,2021 View PDF
2021-10-22 Financial Results for the Quarter ended September 30,2021 View PDF
2021-10-15 Board Meeting for Approval of Quarterly Financials View PDF
2021-09-09 Appointment of Chief Executive View PDF
2021-09-02 Board Meeting for appointment of CEO View PDF
2021-08-31 New Directors Elected View PDF
2021-08-23 Transmission of Quarterly Report View PDF
2021-08-12 Financial Results for 2nd Quarter View PDF
2021-08-10 Notice of EOGM View PDF
2021-08-05 Board Meeting View PDF
2021-07-19 Fixation of Number of Directors View PDF
2021-05-24 Credit/Dispatch of Bonus Shares Certificates View
2021-05-21 Shareholders Resolutions passed in 38th AGM of the Company View PDF
2021-05-21 Shareholders Resolutions passed in 38th AGM of the Company View PDF
2021-05-20 Final Cash Dividend FY 2020 View
2021-04-29 Transmission of Quarterly Report for the Period Ended 31 March 2021 View PDF
2021-04-29 Financial Results for the Quarter Ended March 31, 2021 View PDF
2021-04-21 CORPORATE BRIEFING SESSION-HIGHNOON LABORATORIES LIMITED View PDF
2021-04-21 Board Meeting View PDF
2021-04-07 Transmission of Annual Report for FYE 31 December 2020 (Single Combined File) View PDF
2021-04-06 Transmission of Annual Report FYE 31 December 2020 View PDF
2021-04-06 Transmission of Annual Report FYE 31 December 2020 View PDF
2021-04-06 Notice of Annual General Meeting View PDF
2021-03-25 Issue of Bonus Shares View PDF
2021-03-25 Financial Results For The Year Ended 31 December 2020 View PDF
2021-03-18 Board Meeting View PDF

About Company

Highnoon Laboratories Limited was incorporated in Pakistan under the Companies Act, 2017. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and allied consumer products.

Address
17.5 Kilometer Multan Road, Lahore.
Website
www.highnoon-labs.com
Key People
Dr. Adeel Abbas Haideri CEO
Mr. Tausif Ahmad Khan Chairman
Ms. Mahnoor Ather Company Secretary

Page description

HINOON (Highnoon Laboratories Limited) listed in PSX,ALLSHR,KMIALLSHR,KSE100,MII30. HINOON Share Price / Stock Price is 725.00 PKR. You can also check; Share Price History, HINOONPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.

HINOON Share Price HINOON Stock Price Highnoon Laboratories Limited psx stock kse100 stock HINOON Stock Price ALLSHR KMIALLSHR KSE100 MII30 Share price History HINOON Payouts Annoucements Snapshot HINOON Address HINOON CEO Book Value Price/Book Ratio Dividend Yield Earning Per Share Net Profit Margin Gross Profit Margin Price to Sales Ratio Long Term Debt to Equity Interest Cover (Times) Equity to Assets (%) Current Ratio (Times) Cash Payout Ratio Technical Indicators Moving Averages HINOON Chairperson HINOON Secretary HINOON Website About HINOON

My Watchlist

Not logged in, please login to view watchlist!

Today's Market Performers KSE100

Change
loading

Financial literacy is your key to success and a promise of a secure future in turbulent times. We offer you the right education and resources you need to achieve your financial dreams. Sarmaaya is a trusted source of research and information about Forex, Mutual Funds, and Stocks. Our widgets, tools and calculators aid in identifying potential investment opportunities and valuable insights that can help achieve your short and long-term financial goals.

© 2024 SARMAAYA.PK

Sarmaaya Financials Private Limited is a Pakistan Stock Exchange (PSX) authorized data redistributor. Sarmaaya & CS Solutions (Pvt.) Limited (CS) do not guarantee the timeliness, accurateness, or completeness of any data or information on the website. Sarmaaya & CS makes no warranties, express or implied, as to Sarmaaya & CS or any data or values relating thereto or results to be obtained therefrom, and expressly disclaims all warranties of merchantability and fitness for a particular purpose with respect thereto. To the maximum extent allowed by law, Sarmaaya & CS, its licensors, and their respective employees, contractors, agents, suppliers and vendors shall have no liability or responsibility whatsoever for any injury or damages – whether direct, indirect, consequential, incidental, punitive or otherwise – arising in connection with Sarmaaya & CS or any data or values relating thereto – whether arising from their negligence or otherwise. Nothing in the website shall constitute or be construed as an offering of financial instruments or as investment advice or investment recommendations (i.e., recommendations as to whether or not to “buy”, “sell”, “hold”, or to enter or not to enter into any other transaction involving any specific interest or interests) by Sarmaaya & CS or a recommendation as to an investment or other strategy by Sarmaaya & CS. Data and other information available via the website should not be considered as information sufficient upon which to base an investment decision.